Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder Cancer

SIMPLE SUMMARY: Gallbladder cancer (GBC) is an aggressive malignancy with poor prognosis. Currently, therapeutic options are mostly limited to palliative chemotherapy. Considering the advances of immunotherapy, we assessed the expression of the programmed cell death ligand-1 (PD-L1) as the most wide...

Descripción completa

Detalles Bibliográficos
Autores principales: Albrecht, Thomas, Brinkmann, Fritz, Albrecht, Michael, Lonsdorf, Anke S., Mehrabi, Arianeb, Hoffmann, Katrin, Kulu, Yakup, Charbel, Alphonse, Vogel, Monika N., Rupp, Christian, Köhler, Bruno, Springfeld, Christoph, Schirmacher, Peter, Roessler, Stephanie, Goeppert, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038183/
https://www.ncbi.nlm.nih.gov/pubmed/33918309
http://dx.doi.org/10.3390/cancers13071682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038183/
https://www.ncbi.nlm.nih.gov/pubmed/33918309
http://dx.doi.org/10.3390/cancers13071682

Ejemplares similares